Search Results 1171-1180 of 17031 for Prenatal Pilgrimage

1. Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension - Mayo Clinic

   If female: planned or known pregnancy, positive urine or serum pregnancy test, or lactating/breastfeeding; Previous treatment with emricasan or active ...

2. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

   Negative serum pregnancy test within 72 hours before starting study treatment in women with childbearing potential;; Women of childbearing potential and men ...

3. Publications - Trish J. Simner, Ph.D. - Mayo Clinic

   Harris H, Stambaugh H, Jacobs E, Bhalodi A, Fisher M, Lu J, Tekle T, Humphries R, Simner PJ. Defining Clinical and Laboratory Standards Institute Antimicrobial ...

4. A Wish Realized: Genetic testing solves a family medical mystery - Mayo Clinic News Network

   “They monitored this pregnancy and thought everything would be OK. In hind sight, we were watching the wrong thing.” Roughly 12 hours after birth, Jordyn ...

5. Surgery - Clinical trials

   This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

6. Publications - Anuradha Luke, M.D. - Mayo Clinic

   McCoy RG, Juntunen MB, Ridgeway JL, Hentz JG, Glasgow AE, Liedl C, Murley BM, Warrington CE, Sundt WJ, Krpata TS, Haugo OA, Lampman MA, Fink AL, ...

7. General Internal Medicine - Clinical trials

   The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

8. Nilotinib and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia - Mayo Clinic

   Negative serum pregnancy test done ≤ 7 days prior to registration, for women of childbearing potential only; Provide informed written consent; Willing to ...

9. A Study to Evaluate Pomalidomide to Treat Bleeding in Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

   Females of childbearing potential (FCBP)† must adhere to the pregnancy testing schedule mandated by the POMALYST REMS® program. Ability to understand and ...

10. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism - Mayo Clinic

    ... pregnancy testing will be performed throughout the trial. Sexually active women of childbearing potential who are unwilling to use highly effective ...